Cargando…

Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity

Mitogen-activated protein kinase-8-interacting protein 2 (MAPK8IP2) is a scaffold protein that modulates MAPK signal cascades. Although MAPK pathways were heavily implicated in prostate cancer progression, the regulation of MAPK8IP2 expression in prostate cancer is not yet reported. We assessed MAPK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jian, Liu, Wang, Lin, Bi-Yun, Li, Jean C, Lu, Jane, Li, Ben-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Invited Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069696/ https://www.ncbi.nlm.nih.gov/pubmed/35975362 http://dx.doi.org/10.4103/aja202240

Ejemplares similares

MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer
por: Zeng, Zhenhao, et al.
Publicado: (2022)

Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer
por: Luo, Jun
Publicado: (2016)

Loss of MAPK8IP3 Affects Endocytosis in Neurons
por: Snead, Amanda M., et al.
Publicado: (2022)

Conundrum of IP(6)
por: Vucenik, Ivana
Publicado: (2015)

p38 MAPK Inhibition Mitigates Hypoxia-Induced AR Signaling in Castration-Resistant Prostate Cancer
por: Cheung, Serina, et al.
Publicado: (2021)

Transurethral resection of the prostate stricture management
por: Wang, Jian-Wei, et al.
Publicado: (2019)

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
por: Shorning, Boris Y., et al.
Publicado: (2020)

Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

The HIF/PHF8/AR axis promotes prostate cancer progression
por: Tong, D, et al.
Publicado: (2016)

Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration
por: Ricks, Christian B., et al.
Publicado: (2014)

Scaffolding during the cell cycle by A-kinase anchoring proteins
por: Han, B., et al.
Publicado: (2015)

Design and criteria of electrospun fibrous scaffolds for the treatment of spinal cord injury
por: Vigani, Barbara, et al.
Publicado: (2017)

Molecular signaling involving intrinsically disordered proteins in prostate cancer
por: Russo, Anna, et al.
Publicado: (2016)

Non-nuclear AR Signaling in Prostate Cancer
por: Zamagni, Alice, et al.
Publicado: (2019)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer
por: Xu, Jin, et al.
Publicado: (2019)

PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers
por: Yang, Min, et al.
Publicado: (2021)

Multiparametric ultrasound in the detection of prostate cancer: a systematic review
por: Postema, Arnoud, et al.
Publicado: (2015)

Commentary on “Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies)”
por: Koochekpour, Shahriar
Publicado: (2015)

Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators
por: Takahashi, Sayuri, et al.
Publicado: (2023)

Prognostic value of CtIP/RBBP8 expression in breast cancer
por: Soria-Bretones, Isabel, et al.
Publicado: (2013)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

MiR-942-3p as a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway
por: Liu, Wenjia, et al.
Publicado: (2022)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Gene Expression Studies to Identify Significant Genes in AR, MTOR, MAPK Pathways and their Overlapping Regulatory Role in Prostate Cancer
por: Asati, Nimisha, et al.
Publicado: (2019)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Schweizer, Michael T., et al.
Publicado: (2017)

AR Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
por: Jaiswal, Bharti, et al.
Publicado: (2022)

Evaluation of PKM2 and MAPK8IP2 Polymorphism in Ameloblastic Carcinoma: A Retrospective Quantitative Study
por: Khodayari, Abbas, et al.
Publicado: (2012)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
por: Wüstmann, Neele, et al.
Publicado: (2023)

(4aR,8aR)-2,3-Diphenyl-4a,5,6,7,8,8a-hexahydroquinoxaline
por: Wang, Guo-Xi, et al.
Publicado: (2008)

Prostate cancer stem cells
por: Lang, SH, et al.
Publicado: (2009)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Role of chemotherapy in prostate cancer
por: Nader, Rita, et al.
Publicado: (2018)

Vitamin D in prostate cancer
por: Trump, Donald L, et al.
Publicado: (2018)

An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer
por: Zhu, Wei-Zhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpif8dqduqgrvu6kfepk725526